Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
United States, Europe, China, Sweden
Industries Focus
- HealthTech
- Medical Devices
- Biotechnology
Investment Size:
10,000,000 to 50,000,000 USD
Investor Details Founded: 2015
Blue Ocean Capital Group (BOCG) is a venture capital firm focusing on life sciences investments, including biotechnology, medical devices, and health technology. The firm operates in Greater China, the United States, and Northern Europe, aiming to drive innovation and transformation in the healthcare sector.
BOCG's investment strategy emphasizes supporting innovative biotech and medical device companies at various stages, from early to late-stage development. The firm leverages its extensive industry experience and global network to empower portfolio companies, facilitating their growth and success.
As a signatory to the United Nations-supported Principles for Responsible Investment (UN PRI), BOCG is committed to promoting responsible investment practices and sustainable development within the life sciences industry. This commitment reflects the firm's dedication to integrating environmental, social, and governance factors into its investment decisions, ensuring positive impacts for both companies and society.
Requirements
- Innovative biotech and medical device companies
- Strong growth potential
- Alignment with ESG principles
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Boan Biotech
- HighTide Therapeutics
- Ribo Life Science
- Innorna
- Signet Therapeutics
- Koka Lifesciences
- R Plus Health
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$99.00
Claim this Investor
Are you an official representative of Blue Ocean Capital Group?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim